Recent publication: PROSPECT clinical trial

Oct 5, 2021 – The results of the randomized clinical trial PROSPECT (Probiotics to prevent Severe Pneumonia and Endotracheal Colonization Trial) have been published in JAMA: In summary: Among critically ill patients requiring mechanical ventilation, administration of the probiotic L rhamnosus GG compared to placebo, resulted in no significant difference in the development of… Read more »

Hemotion trial: Highlights of Summer 2021

Sep 22, 2021 – Several milestones have been achieved over the last months: 50% enrollment has been reached; Two records were broken: in June, sites collectively enrolled 24 patients! Our previous monthly record was 22 patients; the Sunnybrook team randomized 6 patients in June. A first HEMOTION patient was enrolled in Brazil. We are grateful… Read more »

Recent publication: CONCOR-1 clinical trial

Sep 17, 2021 – The results of the randomized controlled trial CONCOR-1 (Convalescent Plasma for COVID-19 Respiratory Illness) have been published in Nature Medicine: In summary: Convalescent plasma did not reduce the risk of intubation or death in hospitalized patients with COVID-19. However, the study also revealed that the antibody profile in the blood… Read more »

Our students shine at the 2021 Research Days

Jun 10, 2021 – Congratulations to Élisabeth Canitrot, Godwill Abiala, Chartelin Jean Isaac and Thierry Rouleau Bonenfant, each of them recipients of one “Prize for the oral presentation” of their respective projects and, Cécile Duval and Alexandre Bergeron, winners of a “Prize for aid to dissemination” for their respective poster presentations. The presentations were given as… Read more »

Congratulations to Jihad Abou Jamous on MSc thesis submission

Jun 2, 2021 – Jihad Abou Jamous, a student in the Master of Science in Epidemiology program with thesis at Université Laval, made the final submission of his thesis on April 7th. For his work Jihad received the congratulations of the Dean of the Faculty of Graduate and Postdoctoral Studies.

New research publications from our team in the COVID-19 field

May 15, 2021 – On this page, you will find a list of our recent research publications relevant to our work in the COVID-19 field. These highlighted articles are from our team and also involve collaborations. 1: Tremblay K, Rousseau S, Zawati MH, Auld D, Chassé M, Coderre D, Falcone EL, Gauthier N, Grandvaux N, Gros-Louis… Read more »

In brief: COVID-19 and mitigation strategies

Apr 15, 2021 – With the COVID-19 pandemic, research centers were temporarily closed or partially closed, several sites participating in multicenter clinical trials reaffected their staff to patient care and enrollment in non-COVID-19 research was stopped in the ongoing trials. Considering the call and the expectation from CIHR and CFI funded scientists to help with… Read more »

NeurO2 study receives REB approval in Quebec

Mar 11, 2021 – NeurO2 has received Research Ethics Board (REB) approval in the Province of Quebec for the conduct of this multicenter study. Other REB applications are in preparation in other provinces.

Hemotion trial: New national coordinating center in France

Oct 2, 2020 – We are very happy to announce the opening of a new national coordinating center in France for the Hemotion trial. This center will be based in Besançon (Franche Comté) in partnership with the team of Dr. Sébastien Pili-Floury and will aim to initiate the forthcoming recruitment of patients in the Hemotion… Read more »